Yakup Ergün

Yakup Ergün: Ivonescimab (PD-1 × VEGF) and Tarlatamab (DLL3 × CD3) are My Favorite Drugs For Lung Cancer – Even Better Ones Are Yet to Come

Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared an article on X:

“The next generation of immunotherapies for lung cancers
Although there are many drugs currently in development, my current favorites are ivonescimab (PD-1 × VEGF) and tarlatamab (DLL3 × CD3).
Even better ones are yet to come.”
ivonescimab

Title: The next generation of immunotherapies for lung cancers

Authors: Shen Zhao, Hongyun Zhao, Weiwei Yang, Li Zhang

Read Full Article.

Yakup Ergün: Ivonescimab (PD-1 × VEGF) and Tarlatamab (DLL3 × CD3) are My Favorite Drugs For Lung Cancer - Even Better Ones Are Yet to Come

More posts featuring Yakup Ergün.

cancer Hongyun Zhao Li Zhang lung cancers OncoDaily Oncology Shen Zhao Weiwei Yang